---
title: "AbbVie, Devon Energy And More On CNBC's 'Final Trades'"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289461383.md"
description: "CNBC's 'Final Trades' featured AbbVie, Devon Energy, and U.S. Treasuries. AbbVie was highlighted for its expanded Venetoclax label authorization in the EU, with analysts expecting continued momentum despite a slight daily dip. Devon Energy surged 5.8% after upgrading guidance post-merger with Coterra Energy, prompting an Evercore ISI upgrade to Outperform with a $54 target. Experts also recommended U.S. 10-Year and 2-Year Treasuries."
datetime: "2026-06-11T11:51:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289461383.md)
  - [en](https://longbridge.com/en/news/289461383.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289461383.md)
---

# AbbVie, Devon Energy And More On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” **Jason Snipe**, founder and chief investment officer of Odyssey Capital Advisors, picked **AbbVie Inc.** (NYSE:ABBV).

The Chicago-based company’s stock price gained around 12% in the last month, and Snipe expects the momentum to continue.

On May 29, AbbVie announced the European Commission’s authorization of an expanded label for Venetoclax to include additional combinations for previously untreated chronic lymphocytic leukemia.

_Don't forget to check out our premarket coverage here_

**Stephen Weiss**, chief investment officer and managing partner of Short Hills Capital Partners, picked U.S. 10 Year Treasury.

SoFi ‘s **Liz Young Thomas**, meanwhile, recommended **the U.S. 2 Year Treasury**.

AbbVie, on May 29, announced European Commission authorization of expanded label for Venetoclax to include additional combinations in previously untreated chronic lymphocytic leukemia.

**Joseph M. Terranova**, senior managing director for Virtus Investment Partners, named **Devon Energy Corp** (NYSE:DVN) as his final trade.

Devon Energy shares surged on Wednesday after the company issued fresh guidance for 2026 following the completion of its merger with Coterra Energy. The combined business expects to produce about 1.38 million barrels of oil equivalent per day in 2026, with oil output projected at 500,000 barrels per day.

Evercore ISI Group analyst Stephen Richardson upgraded Devon Energy from In-Line to Outperform on Wednesday and set a $54 price target.

## **Price Action**

-   AbbVie shares fell 0.2% to close at $224.95 on Wednesday.
-   Devon Energy shares jumped 5.8% to settle at $46.60 during the session.

**Read Also: Stock Market Today: Dow Jones, S&P 500 Futures Gain Despite Trump's Threats To Iran Amid Stalled Peace Talks—Oracle, CoreWeave, Visa In Focus**

_Photo via Shutterstock_

### Related Stocks

- [DVN.US](https://longbridge.com/en/quote/DVN.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [CTRA.US](https://longbridge.com/en/quote/CTRA.US.md)

## Related News & Research

- [AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full Analysis](https://longbridge.com/en/news/294086753.md)
- [Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/294552786.md)
- [AbbVie (ABBV) Lifted Guidance, Has The Market Already Priced It In?](https://longbridge.com/en/news/294844923.md)
- [Financial Solutions Advisory Group Inc. Purchases New Stake in AbbVie Inc. $ABBV](https://longbridge.com/en/news/294599849.md)
- [AbbVie Inc. $ABBV Shares Bought by Opal Capital LLC](https://longbridge.com/en/news/294190325.md)